Therefore 52% are positive. Tetra Technologies had 32 analyst reports since August 10, 2015 according to SRatingsIntel. BMO Capital Markets boosted their price objective on shares of Biogen from $328.00 to $377.00 and gave the stock a "market perform" rating in a research report on Wednesday, September 13th. The company was maintained on Tuesday, June 13 by UBS. Cowen & Co maintained TETRA Technologies, Inc. The firm earned "Buy" rating on Friday, July 14 by Nomura. They set a "buy" rating and a $345.00 target price for the company. See TETRA Technologies, Inc.
Nepsis Capital Management Inc decreased Rio Tinto Plc (RIO) stake by 62.99% reported in 2017Q2 SEC filing. As of quarter end Eqis Capital Management, Inc. had acquired 2,556 shares growing its stake by 61.1%. Rio Tinto plc (ADR) (NYSE:RIO) has risen 43.73% since October 12, 2016 and is uptrending. It has underperformed by 11.76% the S&P500. On average, analysts predict that Biogen will post $20.48 EPS for the current year. Thirteen equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Therefore 58% are positive. WESCO International, Inc. (WCC) has risen 13.26% since October 12, 2016 and is uptrending.
06/22/2017 - Biogen Idec Inc. had its "market perform" rating reiterated by analysts at Leerink Swann. Alps Advsrs holds 0% of its portfolio in Biogen Inc (NASDAQ:BIIB) for 2,109 shares. Wells Fargo maintained the shares of BIIB in report on Friday, December 4 with "Outperform" rating. More interesting news about Biogen Inc (NASDAQ:BIIB) were released by: Nasdaq.com and their article: "Factory Mutual Insurance Co Buys DowDuPont Inc, Pioneer Natural Resources Co ..." published on October 12, 2017 as well as Seekingalpha.com's news article titled: "Biogen: Problems In Strategy Make It An "Avoid" with publication date: October 06, 2017. The company was upgraded on Thursday, October 5 by Morgan Stanley. Stifel Nicolaus restated a "hold" rating and issued a $300.00 price objective on shares of Biogen in a research note on Thursday. The firm has "Neutral" rating given on Friday, March 11 by Robert W. Baird.
Since May 1, 2017, it had 1 insider buy, and 1 sale for $102,593 activity. On Wednesday, June 7 Lynch Karen S sold $1.17 million worth of Aetna Inc (NYSE:AET) or 7,825 shares. $390,595 worth of KLA-Tencor Corp (NASDAQ:KLAC) shares were sold by Khan Ahmad A.
Investors sentiment decreased to 0.88 in Q2 2017. Beacon Trust Co. raised its position in Biogen by 0.5% in the 1st quarter. It is negative, as 81 investors sold BIIB shares while 321 reduced holdings. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.79% with $210.64 Million sitting short, betting on future declines. Also, CEO Michel Vounatsos bought 1,333 shares of the firm's stock in a transaction that occurred on Monday, February 27th. Biogen Inc Com Us$0.0005 now has $69.87 billion valuation. Moreover, Airain Limited has 0.77% invested in Biogen Inc (NASDAQ:BIIB).
Livforsakringsbolaget Skandia Omsesidigt increased Aetna Inc (AET) stake by 14.02% reported in 2017Q2 SEC filing. 199,358 were accumulated by Chevy Chase Trust Holding. Grandfield & Dodd Limited Liability Corporation reported 0.04% stake. Boyer & Corporon Wealth Mgmt Limited Company holds 0.09% or 782 shares. Bancshares Of Montreal Can holds 442,083 shares. Spark Inv Mngmt Ltd Co reported 33,000 shares. Meeder Asset stated it has 0.15% of its portfolio in Biogen Inc (NASDAQ:BIIB).
Heading into the stock price potential, Biogen Inc. needs to grow just 1.44% to cross its median price target of $338. Meridian Management invested in 1.32% or 9,251 shares. Its up 0.18, from 1.1 in 2017Q1. During the same quarter in the previous year, the company posted $5.21 earnings per share. 21 funds opened positions while 56 raised stakes. They now have a $300.00 price target on the biotechnology company's stock.
Hite Hedge Asset Management Llc holds 2.2% of its portfolio in Western Refining Logistics LP for 255,868 shares. Moreover, Gam Hldgs Ag has 0.01% invested in TETRA Technologies, Inc. Principal Fin Gru Inc owns 901,989 shares. (NYSE:TTI) for 3,355 shares.
Biogen Inc. (NASDAQ:BIIB) traded at an unexpectedly low level on 11/10/2017 when the stock experienced a 0.11% gain to a closing price of $333.19. Van Eck Assocs holds 256,777 shares. Petrus Lta reported 144,418 shares. Bb&T, North Carolina-based fund reported 2,402 shares. Snow L P, Pennsylvania-based fund reported 215,182 shares.
Among 15 analysts covering KLA-Tencor Corporation (NASDAQ:KLAC), 8 have Buy rating, 0 Sell and 7 Hold.
Biogen Inc.is a biopharmaceutical company. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). The Firm focuses on completion fluids and associated services and products, water management, production well testing, offshore rig cooling, compression services and equipment, and offshore services, such as decommissioning and diving.